Role of hormones and growth factors in melanomas

Seminars in Oncology

Volumn 15, Issue 6, 1988, Pages 512-523

  Walker, Michael J ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; HORMONE;

HUMAN; MELANOMA; NONHUMAN; REVIEW;

ANIMALS; GROWTH SUBSTANCES; HORMONES; HUMANS; MELANOMA;

EID: 0024271219     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (175)

1. Prognosis for malignant melanoma in the pregnant woman
2. Malignant melanoma of the choroid with extensive metastases treated by removing secreting tissue of the testicles
3. Removal of testes in treatment of melanoma
4. Studies on pigmentation of endocrine origin
5. Feminization and demasculization of a 17 year old girl by injection of stilbesterol
6. Phase I clinical study of 6amethyl pregn-4-ene 3,11,20 trione (NSC 17256)
7. Phase II study of 6a-methyl pregn-4-ene 3,11,20 trione (NSC-17256)
8. Diethylstibestrol therapy in surgically non resectable malignant melanoma
9. Steroid hormone receptor and melanoma
10. Steroid hormones, receptors and malignant melanoma
11. Oestrogen receptors in human malignant melanoma
12. Incidence of estrogen receptor in benign nevi and human malignant melanoma
13. Phase II study of high dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma
14. Tamoxifen in treatment of malignant melanoma
15. Estrogen and progesterone receptors and tamoxifen in malignant melanoma
16. Southwest Oncology Group. Experience with tamoxifen in metastatic melanoma
17. Endocrine treatment With anti-estrogen, anti-androgen or progestagen of advanced malignant melanoma: Three consecutive phase II trials
18. Changing trends in the clinical and pathological features of melanoma
19. Malignant melanoma: influence of site of lesion and age of patient in female superiority in survival
20. Sex related surivival differences in instances of melanoma
21. Histologic features of tumors and the female superiority in survival from malignant melanoma
22. Possible association between malignant melanoma and breast cancer
23. Oral contraceptives and malignant melanoma
24. Cutaneous melanoma in relation exogenous hormones and reproductive factors
25. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors
26. Influence of estrogen administration on tumor characteristics and survival in women with cutaneous melanoma
27. Melanoma with pregnancy. A report of 115 cases
28. Adverse effect of pregnancy on melanoma: A Reappraisal
29. Effect of pregnancy upon malignant melanoma
30. Malignant melanoma and pregnancy
31. Previous pregnancy as a protective factor against death from melanoma
32. Estrogen receptor in malignant melanoma
33. Estrogen receptor in hamster melanoma HMM1
34. The malignant melanoma of hamsters: III Effects of sex and castration on the growth of the transplanted tumor
35. Sex factors in growth of malignant melanoma in hamsters: In vivo and in vitro correlation
36. Neuroendocrine and endocrine correlates to hamster melanoma growth in vitro
37. Inhibition of hamster melanoma growth by estrogen
38. Effect of estrogen on the growth of the B16 melanoma
39. Further studies on the growth and spread of B 16 murine melanoma
40. Endocrine factors and the growth and spread of B16 murine melanoma
41. Endocrine correlates of human malignant melanoma
42. The effect of tamoxifen on the growth of human melanoma in vitro
43. Estrogen regulation of epidermal growth factor receptor messenger ribonucleic acid
44. Characterization of estrogen responsive transforming activity in human breast cancer cell lines
45. Estrogen induced factor of breast cancer cells partially replaces estrogen to promote tumor growth
46. Malignant Melanoma: An androgen dependent tumor
47. Hormonal influences on growth of B16 murine melanoma
48. In vitro effects of MSH, ACTH, and 17B estradiol on testosterone propionate on Cloudman S91 cell line
49. Effect of triamcinolone acetonide of the growth of NEL-M1. human melanoma cells cultured in the prescence and abscence of growth stimulatory agents
50. Oestrogen and androgen receptors in melanoma
51. Receptors for steroid hormones in human melanoma
52. Dexamethasone, medroxyprogesterone acetate and vindesine modulation of human malignant
53. Effects of estradiol on estrogen receptor, progesterone receptor, tyrosinase in hamster melanoma transplanted into athymic mice
54. Steroid hormone receptors in human melanoma
55. Effect of medroxyprogesterone and an aorta derived cell growth inhibitor on B16 melanoma in mice
56. High incidence and characterization of glucocorticoid receptor in human malignant melanoma
57. Biological Behavior of MM1 hamster melanoma
58. Effect of adrenal manipulation in glucocorticoid receptors in MM1 hamster melanoma
59. Receptor for glucocorticoids in RPM1 3460 melanoma cells
60. Steroid hormone receptor studies in melanoma model system
61. Growth inhibition by glucocorticoids in RPM1 3460 melanoma cells
62. Glucocorticoids and melanoma: receptor properties of dexamethasone sensitive and resistant tumors
63. Glucocorticoid receptors and the effect of glucocorticoids on the growth of B16 melanoma
64. Inhibition of growth of B16 melanoma by glucocorticoids does not result directly from receptor mediated inhibition of tumor cells
65. In vitro growth inhibition of human melanoma cells by glucocorticoids
66. Suppression of DNA synthesis in NEL-M1 human melanoma cells by triamcinolone acetonide
67. Glucocorticoid receptors and cell progression in human melanoma cell lines
68. 3H] uridine incorporation in one of three human melanoma cell lines
69. Laminin increases the release of Type IV collagenase from malignant cells
70. Interaction of ACTH, corticosterone and cyclic nucleotides in Harding-Passey melanoma melanogenesis
71. Glucocorticoid modulation of adrenocorticotropin induced melanogenesis in the Cloudman S91 melanoma
72. Melanotropins
73. The role of RNA and protein synthesis in mediating the action of MSH on mouse melanoma cells
74. Regulation of adenylate cyclase by β melanotropin in M2R melanoma cell line
75. Inhibition by Mellitin and the fluphenazine of melanotropin receptor function and adenylate cyclase in M2R melanoma cell membranes
76. Regulation of cell shape in the Cloudman melanoma cell line
77. αMSH-induced the changes in protein phosphorylation of Cloudman S91 mouse melanoma cells
78. Action of melanotropins on mouse melanoma cell growth in vitro
79. Melanoma cells which require cyclic AMP for growth
80. Dual effect of a melanocyte stimulating hormone on the growth of cuefunel melanoma cell
81. Response of Cloudman S91 melanoma cells to melanocyte stimulating hormones: Enhancement by cytochalasin B
82. Factors regulating growth and pigmentation of melanoma cells
83. 2 phases of the cell cycle
84. Effect of aMSH on melanogenesis and tyrosinase of B16 melanoma
85. 2 but not MSH stimulate the proliferation of pigmented cells in the pinnal epidermis of DBA/2 mouse
86. Alpha tocopheryl succinate inhibits melanocyte stimulating hormone (MSH)-sensitive adenylate cyclase activity in melanoma cells
87. Control of phenotypic expression of cultured melanoma cells by melanocyte stimulating hormone
88. Phosphorylated isomers of L-dopa stimulate MSH binding capacity and responsiveness to MSH in cultured melanoma cells
89. Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c albino locus
90. A melanocyte specific complementary DNA clone whose expression is inducible by melanotropin and isobutylmethyl xanthine
91. Experimental metastasis correlates with cyclic AMP accumulation in B16 melanoma clones
92. Increased serum alpha melanocyte stimulating hormone (Alpha MSH) in human malignant melanoma
93. 1 inhibit the plating efficiency and proliferation of murine melanoma cells (Cloudman S91) in soft agar
94. 2
95. Inhibition of tumor growth in vivo and in vitro by prostaglandin E
96. Prostaglandin analogues as inhibitors of tumor cell DNA synthesis
97. 1
98. 2 in human and murine melanoma cells in culture
99. Inhibition of human melanoma growth by prostaglandin A, D and J analogues
100. In vitro modulation of proliferation and melanization of S91 melanoma cell by prostaglandins
101. Dexamethasone, prostaglandin A and retinoic acid modulation of murine and human melanoma cells grown in soft agar
102. Melatonin: A coordinating signal for mammalian reproduction
103. Die physiolograche funktion der Zirbedruse und ihre therapeutische anwendung
104. Effect of pinealectomy on the melanic tumors of the golden hamster induced by administration of a single dose of 9,10 dimethyl-1,2 benzanthracene
105. The growth and spread of Walker 256 carcinoma in pinealectomized rats
106. Influence of pineal gland on the growth and spread of melanoma in hamsters
107. Role of pinealectomy in Walker 256 carcinoma in rats
108. Reversal by melatonin of the effect of pinealectomy on tumor growth
109. Photoperiodic control of melanoma growth in hamsters: Influence of pinealectomy and melatonin
110. Effect of melatonin on B16 melanoma growth in athymic mice
111. Growth-inhibiting effect of crude pineal extracts on human melanoma cells in vitro is different from that of known synthetic pineal substances
112. Growth factors in cancer and their relationship to oncogenes
113. Growth factors and cancer
114. Growth Factors: Mechanism of action and relation to oncogenes
115. Biology of tumor progression in human melanocytes
116. Extraction of a melanoma growth stimulatory activity from culture medium conditioned by Hs0294 human melanoma cell line
117. Characterization of autostimulatory and transforming growth factors from human melanoma cells
118. Release of an autostimulatory growth activity by human malignant melanoma cells. Cell growth in hormonally defined media
119. Growth factor and cytogenetic abnormalities in melanoma and nevus culture
120. Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanoma
121. Purification of melanoma growth stimulatory activity
122. Immunoaffinity purification of melanoma growth stimulatory activity
123. Melanoma growth stimulatory activity: isolation from human melanoma tumors and characterization of tissue distribution
124. Preparation of a monoclonal antibody to a melanoma growth stimulatory factor released into serum free culture medium by Hs0294 malignant melanoma cells
125. Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to B thromboglobulin
126. Rat transforming growth factor type 1: structure and relation to epidermal growth factor
127. Transforming growth factors produced by retro virus transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factors
128. A native 170,000 epidermal growth factor receptor-kinase complex from shed membrane vesicles
129. Synthesis of messenger RNA's for transforming growth factors a and b and the epidermal growth factor receptor by human tumors
130. Melanoma, growth factors, acanthosis nigrcans, the sign of Leser-Trelet and multiple acrochordons. A possible role for alpha transforming growth factor in cutaneous peraneoplastic syndrome
131. Growth inhibitor from BSC-1 cells closely related to the platelet type B transforming growth factor
132. Type b transforming growth factor: a bifunctional regulation of cellular growth
133. Type b transforming growth factor is a growth stimulator and growth inhibitor
134. Purification and biological properties of type b transforming growth factor from mouse transformed cells
135. Epidermal Growth Factors
136. Epidermal Growth Factors: physical and chemical properties
137. Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000 molecular weight protein precursor
138. Structure of mouse submaxillary messenger RNA encoding epidermal factor and seven related proteins
139. 125I labeled epidermal growth factor to human fibroblasts
140. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences
141. Characterization of growth factors in human ovarian carcinomas
142. Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosome 7 in malignant melanoma
143. Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation
144. Inability of anti-epidermal growth factor receptor monoclonal antibody to block “autocrine” growth stimulation in transforming growth factor secreting melanoma cell
145. Biologic effects of epidermal growth factor on in vitro growth of human tumors
146. Metastatic but not primary melanoma cell line grown in vitro independently of exogenous growth factors
147. Autocrine tumor growth regulation and tumor associated hypoglycemic in murine melanoma
148. Domain structure of human glucocorticoid receptor and its relationship to the v-erb-A oncogene product
149. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells
150. The platelet derived growth factor
151. The molecular biology of platelet derived growth factor
152. The biology of platelet derived growth factor
153. Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet derived growth factor (PDGF) and produce a PDGF-like growth factor
154. bFGF is the putative natural growth factor for human melanocytes
155. Platelet thrombospondin mediates attachment and spreading of human melanoma cells
156. Nerve growth factor-recent developments and perspectives
157. Polypeptide growth factors: some structural and mechanistic considerations
158. Purification of the receptor for nerve growth factor from A875 melanoma cells by affinity chromatography
159. Nerve growth factor receptor on human melanoma cells in culture
160. Purification of the fibroblast growth factor activity from bovine brain
161. Angiogenic factor
162. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino acid sequence of bovine brain acidic FGF
163. Nucleotide sequence of bovine clone encoding the angiogenic protein basic fibroblast growth factor
164. Both normal and tumor cells produce basic fibroblast growth factor
165. In vitro growth promotion in human melanoma cells by fibroblast growth factor
166. Human melanoma cells but not normal melanocytes produce of basic fibroblast growth factor (bFGF)-like activity
167. The stimulation of normal human melanocyte proliferation in vitro by melanocyte growth factor from bovine brain
168. Growth regulation of human melanocytes: Mitogenic factors in extracts of melanoma, astrocytoma and fibroblast cell lines
169. Growth stimulation of human melanocytes: Identification and characterization of melanoma derived melanocyte growth factor (M-McGF)
170. The use of hormone supplemented serum free media in primary cultures
171. Human melanoma-associated antigen p97 is structurally and functionally related to transferrin
172. A diffusible factor restoring contact inhibition of growth to malignant melanocytes
173. Contact inhibitory factor also restores anchorage and serum dependence to hamster melanoma cells